Search
for

    Research

    5 / 1000+ results
      Frontal Fibrosing Alopecia: Clinical Presentations and Prognosis

      research Frontal fibrosing alopecia: clinical presentations and prognosis

      155 citations , September 2008 in “British journal of dermatology/British journal of dermatology, Supplement”
      This study observed that frontal fibrosing alopecia predominantly affects postmenopausal women, can be associated with lichen planus, and may lead to progressive hairline recession, though this progression is not consistent in all cases.
      A Retrospective Study of Frontal Fibrosing Alopecia from North-East India

      research A Retrospective Study of Frontal Fibrosing Alopecia from North-East India

      November 2023 in “Indian Journal of Dermatology”
      This study from North-East India analyzed 21 cases of frontal fibrosing alopecia, noting a high prevalence in post-menopausal women and distinct histological features such as perifollicular lymphocytic infiltrate and hydropic degeneration.

    Community Join

    5 / 8 results

      community My 5 months hair transplant surgery update.

       1008 upvotes 2 weeks ago
      A 26-year-old male actor underwent two hair transplant surgeries to enhance his hairline, with the second surgery by Dr. Abhinav Kumar in Patna yielding natural and satisfactory results. He spent approximately Rs 60,000 ($700) for 1200 fine single hair grafts and plans to consider DHT blockers like finasteride and minoxidil to maintain his hair.

      community My 5 months Hair Transplant Surgery update.

       851 upvotes 8 months ago
      A 27-year-old actor shared his positive experience with two hair transplant surgeries, highlighting the importance of customization and detail for a natural look. He is taking finasteride to prevent future hair loss.

      community Prolactin the Cause of Hair Loss? ABS-201 the Cure?

       29 upvotes 2 months ago
      Prolactin may contribute to hair loss, but targeting its receptor won't cure androgenetic alopecia. ABS-201 could be a useful alternative or adjuvant therapy, similar to JAK inhibitors, but not more effective than HMI-115.